Ceftriaxone Sodium Market, By Formulation (Powder for Injection, Premixed Injection Solution, and Lyophilized Vials), By Strength (250 mg, 500 mg, 1 g, 2 g, and Other Strengths), By Route of Administration (Intravenous and Intramuscular), By Indication (Lower Respiratory Tract Infections, Acute Bacterial Otitis Media, Skin and Skin Structure Infections, Urinary Tract Infections, Uncomplicated Gonorrhea, Pelvic Inflammatory Disease, Bacterial Septicemia, Bone and Joint Infections, Intra-abdominal Infections, Meningitis, Surgical Prophylaxis, and Others), By Age Group (Adult, Pediatric, and Geriatric), By Type (Brand and Generic), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Diagnostic and Research Laboratories), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)